A national labour market report highlights labour trends in the expandingly diverse biotech sector that now also includes medical cannabis, digital health and artificial intelligence, and sustainable development.
CanAscen’s business concept is to be a differentiated leader in the premium segment of the cannabinoid market. The CanAscen Group (CAG) will achieve this through technological partnerships with established and successful producers of a variety of cannabinoid products.
The CanAscen Group is a collective of experts and specialists striving to create premium products for global connoisseurs
The CanAscen Group is uniquely positioned with expertise in multiple vertical sectors; Cannabis, Science, Agriculture and Business internationally. With the synergism of the team, and a view to the future our team is well-positioned to ensure CAG’s leadership in the global cannabis space.